Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 48

The DOI matches its Crossref record.

Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation

Dong, Xiaoqiong, Thomas, David D. · 2014 · Biochemical and Biophysical Research Communications

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2014.04.166

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 44

  1. Gwathmey, 1987, Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure, Circ. Res., 61, 70, 10.1161/01.RES.61.1.70 · DOI · Paper page
  2. Bers, 2006, Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts, J. Pharmacol. Sci., 100, 315, 10.1254/jphs.CPJ06001X · DOI · Paper page
  3. Inesi, 2014, Ca2+/H+ exchange, lumenal Ca2+ release and Ca2+/ATP coupling ratios in the sarcoplasmic reticulum ATPase, J. Cell Commun. Signal., 8, 5, 10.1007/s12079-013-0213-7 · DOI
  4. Cantilina, 1993, Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+, J. Biol. Chem., 268, 17018, 10.1016/S0021-9258(19)85295-X · DOI · Paper page
  5. Mattiazzi, 2005, Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions, Cardiovasc. Res., 68, 366, 10.1016/j.cardiores.2005.08.010 · DOI · Paper page
  6. Gwathmey, 2013, Targeting sarcoplasmic reticulum calcium ATPase by gene therapy, Hum. Gene Ther., 24, 937, 10.1089/hum.2013.2512 · DOI
  7. Minamisawa, 1999, Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy, Cell, 99, 313, 10.1016/S0092-8674(00)81662-1 · DOI · Paper page
  8. Hoshijima, 2002, Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery, Nat. Med., 8, 864, 10.1038/nm739 · DOI · Paper page
  9. Iwanaga, 2004, Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats, J. Clin. Invest., 113, 727, 10.1172/JCI18716 · DOI · Paper page
  10. Jessup, 2011, Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure, Circulation, 124, 34, 10.1161/CIRCULATIONAHA.111.022889 · DOI · Paper page
  11. James, 1989, Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum, Nature, 342, 90, 10.1038/342090a0 · DOI · Paper page
  12. Chen, 2010, Ca2+ binding to site I of the cardiac Ca2+ pump is sufficient to dissociate phospholamban, J. Biol. Chem., 285, 3253, 10.1074/jbc.M109.080820 · doi:10.1074/jbc.m109.080820
  13. Chen, 2003, Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents, J. Biol. Chem., 278, 48348, 10.1074/jbc.M309545200 · DOI · Paper page
  14. Morita, 2008, Interaction sites among phospholamban, sarcolipin, and the sarco(endo)plasmic reticulum Ca(2+)-ATPase, Biochem. Biophys. Res. Commun., 369, 188, 10.1016/j.bbrc.2007.11.098 · DOI · Paper page
  15. Asahi, 2000, Physical interactions between phospholamban and sarco(endo)plasmic reticulum Ca2+-ATPases are dissociated by elevated Ca2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP, J. Biol. Chem., 275, 15034, 10.1074/jbc.275.20.15034 · DOI
  16. Bal, 2012, Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals, Nat. Med., 18, 1575, 10.1038/nm.2897 · DOI · Paper page
  17. Mueller, 2004, Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer, Biochemistry, 43, 8754, 10.1021/bi049732k · DOI
  18. James, 2012, Protein–protein interactions in calcium transport regulation probed by saturation transfer electron paramagnetic resonance, Biophys. J., 103, 1370, 10.1016/j.bpj.2012.08.032 · DOI · Paper page
  19. Bidwell, 2011, Phospholamban binds with differential affinity to calcium pump conformers, J. Biol. Chem., 286, 35044, 10.1074/jbc.M111.266759 · DOI · Paper page
  20. Gruber, 2012, Phospholamban mutants compete with wild type for SERCA binding in living cells, Biochem. Biophys. Res. Commun., 420, 236, 10.1016/j.bbrc.2012.02.125 · doi:10.1016/j.bbrc.2012.02.125
  21. Karim, 2004, Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone, Proc. Natl. Acad. Sci. U.S.A., 101, 14437, 10.1073/pnas.0402801101 · doi:10.1073/pnas.0402801101
  22. Nesmelov, 2007, Rotational dynamics of phospholamban determined by multifrequency electron paramagnetic resonance, Biophys. J., 93, 2805, 10.1529/biophysj.107.108910 · DOI
  23. Gustavsson, 2013, Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban, Proc. Natl. Acad. Sci. U.S.A., 110, 17338, 10.1073/pnas.1303006110 · DOI · Paper page
  24. Karim, 2006, Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA, J. Mol. Biol., 358, 1032, 10.1016/j.jmb.2006.02.051 · DOI · Paper page
  25. Li, 2012, Structural and functional dynamics of an integral membrane protein complex modulated by lipid headgroup charge, J. Mol. Biol., 418, 379, 10.1016/j.jmb.2012.02.011 · DOI
  26. Fernandez, 1980, Highly purified sarcoplasmic reticulum vesicles are devoid of Ca2+- independent (‘basal’) ATPase activity, Biochim. Biophys. Acta, 599, 552, 10.1016/0005-2736(80)90199-6 · doi:10.1016/0005-2736(80)90199-6
  27. Stokes, 1990, Three-dimensional crystals of CaATPase from sarcoplasmic reticulum. Symmetry and molecular packing, Biophys. J., 57, 1, 10.1016/S0006-3495(90)82501-7 · DOI
  28. Bishop, 1988, (Iodoacetamido)fluorescein labels a pair of proximal cysteines on the Ca2+-ATPase of sarcoplasmic reticulum, Biochemistry, 27, 5233, 10.1021/bi00414a043 · DOI
  29. Cornea, 1997, Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry, 36, 2960, 10.1021/bi961955q · DOI · Paper page
  30. Mascioni, 2002, Solid-state NMR and rigid body molecular dynamics to determine domain orientations of monomeric phospholamban, J. Am. Chem. Soc., 124, 9392, 10.1021/ja026507m · doi:10.1021/ja026507m
  31. Zamoon, 2005, Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation, Proc. Natl. Acad. Sci. U.S.A., 102, 4747, 10.1073/pnas.0406039102 · DOI
  32. Buck, 2003, Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies, Protein Expr. Purif., 30, 253, 10.1016/S1046-5928(03)00127-X · DOI
  33. Reddy, 2003, Defining the molecular components of calcium transport regulation in a reconstituted membrane system, Biochemistry, 42, 4585, 10.1021/bi026995a · DOI · Paper page
  34. Lockamy, 2011, Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure, Biochem. Biophys. Res. Commun., 408, 388, 10.1016/j.bbrc.2011.04.023 · DOI
  35. Toyoshima, 2003, Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase, Proc. Natl. Acad. Sci. U.S.A., 100, 467, 10.1073/pnas.0237326100 · DOI · Paper page
  36. Olesen, 2007, The structural basis of calcium transport by the calcium pump, Nature, 450, 1036, 10.1038/nature06418 · DOI · Paper page
  37. Hou, 2008, Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex, J. Biol. Chem., 283, 28996, 10.1074/jbc.M804782200 · doi:10.1074/jbc.m804782200
  38. Ferrington, 2002, Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum, Biochemistry, 41, 13289, 10.1021/bi026407t · DOI · Paper page
  39. Gross, 1985, Identification of plasmalogen as the major phospholipid constituent of cardiac sarcoplasmic reticulum, Biochemistry, 24, 1662, 10.1021/bi00328a014 · DOI · Paper page
  40. Espinoza-Fonseca, 2011, Atomic-level characterization of the activation mechanism of SERCA by calcium, PLoS One, 6, e26936, 10.1371/journal.pone.0026936 · DOI
  41. Hou, 2012, Two-color calcium pump reveals closure of the cytoplasmic headpiece with calcium binding, PLoS One, 7, e40369, 10.1371/journal.pone.0040369 · doi:10.1371/journal.pone.0040369
  42. Jensen, 2006, Modulatory and catalytic modes of ATP binding by the calcium pump, EMBO J., 25, 2305, 10.1038/sj.emboj.7601135 · DOI · Paper page
  43. Karim, 2000, Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase, Biochemistry, 39, 10892, 10.1021/bi0003543 · DOI
  44. Humphrey, 1996, VMD: visual molecular dynamics, J. Mol. Graph., 14, 27

Cited by

Metadata

Authors
Dong, X., & Thomas, D. D.
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2014-06
Volume
449
Issue
2
Pages
196-201
ISSN
0006-291X
Cited by
48
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • NIH
  • GM27906 (AR0507220)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.